Strawberry substance tested to boost mobility in artery disease patients

NCT ID NCT06399809

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether fisetin, a natural compound found in strawberries, can reduce aging cells and improve walking ability in 34 people aged 50+ with peripheral artery disease (PAD). Participants will receive either fisetin or a placebo for 4 months. The main goal is to see if fisetin helps them walk farther in 6 minutes, with secondary checks on grip strength and physical performance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fisetin (a flavanol found in strawberries, apples, and persimmons that destroys senescent cells)
What this could lead to
If it works, this could point toward a simple dietary supplement to help people with peripheral artery disease walk farther and feel stronger.
What could go wrong
This is a very small pilot trial with only 34 participants, so results may not apply widely. Fisetin is still experimental, and its long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Northwestern University Feinberg School of Medicine

    RECRUITING

    Chicago, Illinois, 60611-3008, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.